These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 27352931

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.
    Ali AM, Huang Y, Pinheiro RF, Xue F, Hu J, Iverson N, Hoehn D, Coutinho D, Kayani J, Chernak B, Lane J, Hillyer C, Galili N, Jurcic J, Mohandas N, An X, Raza A.
    Blood Adv; 2018 Jun 26; 2(12):1393-1402. PubMed ID: 29903708
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification.
    Uni M, Masamoto Y, Sato T, Kamikubo Y, Arai S, Hara E, Kurokawa M.
    Leukemia; 2019 Jan 26; 33(1):191-204. PubMed ID: 29967380
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O, Nolte F, Mossner M, Komor M, Kmetsch A, Benslasfer O, Reissmann M, Nowak D, Hoelzer D, Thiel E, Hofmann WK.
    Eur J Haematol; 2012 Feb 26; 88(2):144-53. PubMed ID: 21967505
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels.
    Inoue D, Matsumoto M, Nagase R, Saika M, Fujino T, Nakayama KI, Kitamura T.
    Exp Hematol; 2016 Mar 26; 44(3):172-6.e1. PubMed ID: 26700326
    [Abstract] [Full Text] [Related]

  • 36. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM, Tefferi A.
    Mayo Clin Proc; 2016 Feb 26; 91(2):259-72. PubMed ID: 26848006
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dyserythropoiesis of myelodysplastic syndromes.
    Lefèvre C, Bondu S, Le Goff S, Kosmider O, Fontenay M.
    Curr Opin Hematol; 2017 May 26; 24(3):191-197. PubMed ID: 28072603
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
    Laranjeira P, Rodrigues R, Carvalheiro T, Constanço C, Vitória H, Matarraz S, Trindade H, Órfão A, Paiva A.
    Leuk Res; 2015 Mar 26; 39(3):361-70. PubMed ID: 25582385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.